Leukemia: all 5,475 studies
Page 3 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- VA as Maintenance Therapy Post Allo-HSCT in MDS and AMLNot yet recruitingNCT06598384Phase 2
- Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06581081Not applicable
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALLRecruitingNCT06578546Phase 2
- RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CRRecruitingNCT06571825Phase 4
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06564545Phase 2
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06564493Phase 2
- Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with LeukemiaEnrolling by invitationNCT06560879Phase 2
- Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute LeukemiaNot yet recruitingNCT06559644Early Phase 1
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06559345Phase 2
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06557161Phase 2
- Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALLRecruitingNCT06554626Phase 2
- Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT06549790Phase 1
- Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia PatientsEnrolling by invitationNCT06544109Phase 2/3
- Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid LeukemiaRecruitingNCT06537843Phase 2
- Breath Analysis for the Detection of Invasive Fungal InfectionsRecruitingNCT06537726
- VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDSRecruitingNCT06536959Phase 2
- Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AMLRecruitingNCT06536010Not applicable
- Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid LeukemiaRecruitingNCT06535113
- Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)RecruitingNCT06533579Phase 1/2
- Sorafenib Relapase Prophylaxis After HCT With PTBCy RegimenRecruitingNCT06532084Phase 2
- Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT06532058Phase 2
- Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)Not yet recruitingNCT06530810Phase 1
- A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)RecruitingNCT06520098Phase 2
- ELN 2022 in MENAFC ( Middle Eastern or North Coast of Africa ) Patients With Newly AMLNot yet recruitingNCT06512610
- Vitamin A and D Supplementation in Allogeneic HCTRecruitingNCT06508099Phase 2
- A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic SyndromeRecruitingNCT06501196Phase 1
- HEME Home Transfusion ProgramRecruitingNCT06487247Not applicable
- BeFluBu vs FluBuRux Conditioning in Haploidentical HCTRecruitingNCT06477549Phase 2
- Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious RiskRecruitingNCT06475469Not applicable
- CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AMLNot yet recruitingNCT06470841Phase 2
- Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)RecruitingNCT06469307Not applicable
- Relationship Between Serum N/OFQ and Acute Myeloid Cell LeukemiaNot yet recruitingNCT06469047
- ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AMLNot yet recruitingNCT06463327Phase 1
- Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)RecruitingNCT06462365Phase 1
- the Efficacy and Safety of Total Myeloid Irradiation (TMI) in the Treatment of Adult Acute Lymphoblastic LeukemiaNot yet recruitingNCT06461091
- TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) PatientsRecruitingNCT06453902Phase 2
- Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic LeukemiaRecruitingNCT06450067
- VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCTRecruitingNCT06447090Phase 2
- CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHLRecruitingNCT06445803Phase 1
- A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After TransplantationNot yet recruitingNCT06441084Phase 1
- Blinatumomab Maintenance After Allo-HSCTNot yet recruitingNCT06438796Phase 2
- The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic LymphomaNot yet recruitingNCT06434467Phase 3
- PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)RecruitingNCT06430736Phase 2
- Mitoxantrone for Venetoclax Resistant Acute Myeloid LeukemiaRecruitingNCT06429449Phase 1
- Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic LeukemiaRecruitingNCT06427330Phase 2
- Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T CellsRecruitingNCT06420076Phase 1/2
- Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AMLRecruitingNCT06420063Phase 1/2
- IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AMLRecruitingNCT06418776Phase 3
- Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.RecruitingNCT06409767Not applicable
- Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell MalignanciesRecruitingNCT06408194Phase 1
- Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML PatientsRecruitingNCT06394011Phase 2
- Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALLRecruitingNCT06393985Phase 2
- Observational Study on Invasive Fungal Infection Incidence in Ph-neg Acute Lymphoblastic Leukemia PatientsRecruitingNCT06392581
- The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBPRecruitingNCT06390306
- A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid LeukemiaNot yet recruitingNCT06387420Phase 1/2
- Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AMLNot yet recruitingNCT06385808Not applicable
- Haplo-cord HCT vs. Haplo-HCT for T-ALL PatientsRecruitingNCT06381817Phase 3
- Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic LeukaemiaRecruitingNCT06379282Not applicable
- MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLLNot yet recruitingNCT06367374Phase 2
- Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)Not yet recruitingNCT06367114Phase 2
- Biological and Clinical Efficacy of Shingrix in Patients With CLLNot yet recruitingNCT06364033Not applicable
- Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.RecruitingNCT06360718Not applicable
- CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+RecruitingNCT06355739Not applicable
- Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) TrialRecruitingNCT06355583Phase 2
- Fasting Mimicking Diet With Chemotherapy in Patients With LeukemiaRecruitingNCT06353698Not applicable
- BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in ChildrenNot yet recruitingNCT06347458Phase 1
- MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)RecruitingNCT06345365Phase 3
- Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)RecruitingNCT06345027Phase 1
- AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell LymphomasRecruitingNCT06340737Phase 1
- Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After TransplantationRecruitingNCT06339775Phase 4
- Ma-Spore ALL 2020 StudyRecruitingNCT06336395Phase 2
- Total Body Irradiation Treatments for Patients Treated at European Institute of OncologyRecruitingNCT06335277
- Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.RecruitingNCT06334835
- Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCLNot yet recruitingNCT06333509Phase 1/2
- A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AMLRecruitingNCT06329999Not applicable
- Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.RecruitingNCT06328179Not applicable
- Incidence of Platelet Refractoriness in Adult Acute Leukemia Patients Receiving Prestorage Filtered Blood and Comparing With Historical ControlRecruitingNCT06325553
- Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT MutationRecruitingNCT06316960Phase 2
- Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell TransplantRecruitingNCT06315309Phase 2
- Revumenib in Combination With 7+3 + Midostaurin in AMLRecruitingNCT06313437Phase 1
- The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic LeukemiaRecruitingNCT06307600Early Phase 1
- MRD Response-adapted Allo-HSCT for Adverse-risk AMLRecruitingNCT06301425Not applicable
- The Evaluation and Comparison of BCR-ABL p210 mRNA Transcripts (%IS Unit) Results Between Dr. PCR™ BCR-ABL1 Major IS Detection Kit (Optolane) and QXDx™ BCR-ABL %IS Kit (Bio-Rad) in Chronic Myeloid Leukemia PatientsRecruitingNCT06301321
- PTCy and ATG for MSD and MUD TransplantsRecruitingNCT06299462Phase 1/2
- Study of REM-422 in Patients With AML or Higher Risk MDSRecruitingNCT06297941Phase 1
- DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology ClinicsRecruitingNCT06296368Not applicable
- Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and GenomicsNot yet recruitingNCT06295029
- Raman Spectroscopy Compared to Flow CytometryRecruitingNCT06291428
- Chronic Kidney Disease Patient in Chronic Myloied LeukemiaNot yet recruitingNCT06266975
- Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell TransplantRecruitingNCT06265584Phase 2
- RAT-HEMATO : Return to Work After Malignant HemopathyRecruitingNCT06262789Not applicable
- Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia PatientsNot yet recruitingNCT06252584Phase 1
- Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell TransplantationRecruitingNCT06247501Phase 2
- UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid LeukemiaRecruitingNCT06245746Phase 1
- Coagulopathy in Childhood Acute Lymphoblastic LeukaemiaNot yet recruitingNCT06242353
- MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult PatientsRecruitingNCT06237192Not applicable
- Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity TestRecruitingNCT06233526Not applicable
- Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AMLRecruitingNCT06232694Not applicable
- A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX GenesRecruitingNCT06229912Phase 2